BIOFACTORS

Scope & Guideline

Championing High-Impact Research in Life Sciences

Introduction

Welcome to the BIOFACTORS information hub, where our guidelines provide a wealth of knowledge about the journal’s focus and academic contributions. This page includes an extensive look at the aims and scope of BIOFACTORS, highlighting trending and emerging areas of study. We also examine declining topics to offer insight into academic interest shifts. Our curated list of highly cited topics and recent publications is part of our effort to guide scholars, using these guidelines to stay ahead in their research endeavors.
LanguageEnglish
ISSN0951-6433
PublisherWILEY
Support Open AccessNo
CountryUnited States
TypeJournal
Convergefrom 1988 to 1995, from 1997 to 2024
AbbreviationBIOFACTORS / Biofactors
Frequency6 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
Address111 RIVER ST, HOBOKEN 07030-5774, NJ

Aims and Scopes

The journal BIOFACTORS focuses on the multifaceted roles of bioactive compounds and their implications for health, disease prevention, and therapeutic strategies. It encompasses a wide range of biological and biochemical research, emphasizing translational applications and novel therapeutic insights.
  1. Bioactive Compounds and Their Mechanisms:
    Research on the mechanisms of action of various bioactive compounds, including phytochemicals, vitamins, and other natural products, and their roles in health and disease.
  2. Cancer Biology and Therapeutics:
    Studies exploring the molecular pathways involved in cancer progression, resistance mechanisms, and the potential of bioactive compounds as therapeutic agents.
  3. Metabolic and Endocrine Disorders:
    Investigations into the effects of bioactive substances on metabolic syndromes, obesity, diabetes, and related endocrine disorders.
  4. Neurobiology and Neurodegenerative Diseases:
    Research focused on the neuroprotective effects of various compounds and their roles in neurodegenerative diseases such as Alzheimer's and Parkinson's.
  5. Inflammation and Immunomodulation:
    Exploring the roles of bioactive compounds in modulating inflammatory responses and their therapeutic implications in chronic diseases.
  6. Microbiome and Gut Health:
    Studies examining the interactions between dietary components, gut microbiota, and their influence on overall health and disease outcomes.
  7. Oxidative Stress and Antioxidant Defense:
    Research on the role of oxidative stress in disease processes and the therapeutic potential of antioxidants derived from natural sources.
  8. Molecular and Cellular Biology:
    Investigations into cellular signaling pathways, gene expression, and the role of non-coding RNAs in various biological processes.
The journal BIOFACTORS is currently witnessing several emerging themes that reflect the evolving landscape of research in bioactive compounds and their applications in health and disease.
  1. Personalized Nutrition and Metabolism:
    An increasing focus on how individual variations in metabolism affect responses to dietary bioactive compounds, leading to personalized nutrition strategies.
  2. Nanotechnology in Drug Delivery:
    Emerging research on the use of nanotechnology to enhance the delivery and efficacy of bioactive compounds in therapeutic applications.
  3. Gut-Brain Axis:
    Growing interest in the interactions between gut microbiota and neurological health, highlighting the role of dietary components in influencing brain function.
  4. Plant-Derived Compounds in Chronic Disease Management:
    A rising trend in exploring the therapeutic potential of plant-derived compounds in managing chronic diseases such as diabetes, cardiovascular diseases, and cancer.
  5. Immunotherapy and Bioactive Compounds:
    Increased exploration of the role of bioactive compounds in enhancing immunotherapeutic approaches for cancer and other diseases.
  6. Epigenetics and Bioactive Compounds:
    Emerging research on how bioactive compounds can influence epigenetic mechanisms, potentially affecting gene expression and disease outcomes.
  7. Sustainability and Bioactive Compounds:
    A growing emphasis on sustainable sourcing and the environmental impact of bioactive compounds, reflecting a broader trend towards environmentally conscious research.

Declining or Waning

While BIOFACTORS has maintained a robust focus on various aspects of bioactive compounds and their effects, certain themes appear to be declining in prominence based on recent publication trends.
  1. Traditional Herbal Medicine:
    There has been a noticeable decrease in publications focused on traditional herbal medicines and their applications, which may reflect a shift towards more mechanistic and targeted studies involving specific bioactive compounds.
  2. Basic Biochemical Pathways:
    Research focusing solely on basic biochemical pathways without direct relevance to health outcomes or therapeutic implications seems to be less frequent, indicating a trend towards more applied research.
  3. Animal Models of Disease:
    While animal studies remain vital, there is a waning interest in certain animal model studies, particularly those that do not translate directly to human health or therapeutic strategies.
  4. Epidemiological Studies:
    Epidemiological research examining population-level health outcomes related to bioactive compounds appears to be less emphasized in recent issues, possibly overshadowed by more mechanistic studies.

Similar Journals

INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE

Advancing the frontiers of molecular medicine.
Publisher: SPANDIDOS PUBL LTDISSN: 1107-3756Frequency: 12 issues/year

International Journal of Molecular Medicine is a prestigious publication dedicated to advancing the field of molecular medicine through innovative research and scholarly dialogue. Published by Spandidos Publications Ltd in Greece, this journal has successfully provided a platform for academics and professionals alike since its inception in 1998. With an impressive 2023 Q1 ranking in Medicine (Miscellaneous) and a Q2 ranking in Genetics, the journal maintains a vital role in disseminating high-quality research, underscored by its strong performance in the Scopus rankings, particularly in the realm of genetics where it ranks 28 out of 347. Researchers will benefit from its comprehensive scope, which encompasses a wide range of topics within molecular biology, genetics, and their clinical applications. Although the journal does not operate under an open access model, it remains influential, providing critical insights that contribute significantly to the understanding and development of molecular therapeutic strategies and innovations.

FREE RADICAL BIOLOGY AND MEDICINE

Exploring the Dynamics of Free Radicals in Health and Disease
Publisher: ELSEVIER SCIENCE INCISSN: 0891-5849Frequency: 12 issues/year

FREE RADICAL BIOLOGY AND MEDICINE, published by Elsevier Science Inc, is a premier journal dedicated to the field of biochemistry and medical physiology. With an ISSN of 0891-5849 and an E-ISSN of 1873-4596, this journal stands out with its impressive ranking in the 2023 category quartiles: Q1 in Biochemistry and Q1 in Physiology (medical). Specifically, it has achieved a remarkable position of 29th out of 438 in Biochemistry and 8th out of 113 in Physiology, placing it firmly in the 93rd percentile of its field, as per Scopus rankings. Since its inception in 1987, the journal has focused on advancing the understanding of free radicals and their role in biological processes, encompassing a wide range of topics from oxidative stress to therapeutic applications. Although it does not currently offer open access, the journal's rigorous peer-review process and impactful research ensure that it remains a valuable resource for researchers and professionals seeking to explore the intricate relationships between free radicals and health. The journal's headquarters are located at STE 800, 230 Park Ave, New York, NY 10169, reflecting its esteemed place within the scientific community and commitment to high-quality research.

MOLECULAR AND CELLULAR BIOLOGY

Driving Innovation in Molecular and Cellular Science
Publisher: TAYLOR & FRANCIS INCISSN: 0270-7306Frequency: 24 issues/year

MOLECULAR AND CELLULAR BIOLOGY, published by TAYLOR & FRANCIS INC, stands as a preeminent platform for researchers, professionals, and students engaged in the dynamic field of molecular and cellular biology. Established in 1981 and ongoing into 2024, the journal features cutting-edge research that spans across vital sub-disciplines, garnering a strong impact in its contributions to the scientific community. With an impressive Q2 ranking in Cell Biology and Q1 ranking in Molecular Biology for 2023, it consistently publishes high-quality articles that reflect the latest advancements and discoveries within the field. The journal is particularly well-regarded for its rigorous peer-review process and commitment to scientific excellence, making it an invaluable resource for those seeking to deepen their understanding of molecular mechanisms and cellular processes. Although not open access, the journal offers diverse access options for researchers to reach the latest findings. By maintaining a strong focus on biochemistry, genetics, and molecular biology, MOLECULAR AND CELLULAR BIOLOGY remains essential reading for anyone looking to contribute to or stay informed about significant developments within this pivotal area of study.

BIOSCIENCE REPORTS

Pioneering Insights in Biophysics and Molecular Biology
Publisher: PORTLAND PRESS LTDISSN: 0144-8463Frequency: 6 issues/year

BIOSCIENCE REPORTS, published by Portland Press Ltd, is a prestigious journal dedicated to advancing the fields of biochemistry, biophysics, cell biology, and molecular biology. Founded in 1981, the journal has established itself as a vital resource for researchers and professionals, boasting a significant impact factor and high rankings within its categories, including Q2 in Biochemistry and Q1 in Biophysics as of 2023. The journal’s commitment to high-quality, peer-reviewed research ensures that it remains an influential platform for the dissemination of cutting-edge scientific findings. While it operates under a traditional subscription model, it offers various access options to accommodate the needs of the scientific community. With ongoing publication through 2024, BIOSCIENCE REPORTS continues to play a crucial role in shaping discussions in the life sciences and fostering innovative research in biology.

ARCHIVES OF PHYSIOLOGY AND BIOCHEMISTRY

Empowering Researchers with Cutting-Edge Discoveries
Publisher: TAYLOR & FRANCIS LTDISSN: 1381-3455Frequency: 5 issues/year

Archives of Physiology and Biochemistry, published by Taylor & Francis Ltd, is a renowned journal that has been pivotal in advancing knowledge and research in the fields of physiology and biochemistry since its inception. With an impact factor reflective of its significant contributions, this journal is categorized in Q2 in Medicine (miscellaneous) and Q3 in Physiology, underscoring its relevance and scholarly impact within the scientific community. The journal publishes original research articles, review papers, and innovative methodologies that explore the intricate relationships between physiological functions and biochemical processes. With its commitment to fostering scientific discourse, the Archives of Physiology and Biochemistry serves as an essential resource for researchers, professionals, and students alike, providing insights and evidence that drive forward the frontiers of medical and physiological science. The journal is accessible in both print and online formats, ensuring that critical research reaches a wide audience.

EXPERIMENTAL AND MOLECULAR MEDICINE

Elevating biomedical knowledge through peer-reviewed excellence.
Publisher: SPRINGERNATUREISSN: 1226-3613Frequency: 12 issues/year

EXPERIMENTAL AND MOLECULAR MEDICINE, published by SpringerNature, is a premier open-access journal that has been at the forefront of biomedical research since its establishment in 1996. With a focus on innovative studies in biochemistry, molecular biology, and clinical biochemistry, the journal has consistently maintained a distinguished position within the top quartile (Q1) across multiple categories, underscoring its significant impact in these fields. The journal offers researchers and practitioners a platform for high-quality, peer-reviewed articles that advance our understanding of molecular mechanisms underlying health and disease. As a crucial resource for scholars seeking to explore cutting-edge research and practical advancements, its inclusion in relevant databases such as Scopus reflects an exceptional ranking with notable percentiles—placing it among the best in biomedical sciences. With a commitment to open access, EXPERIMENTAL AND MOLECULAR MEDICINE ensures that findings are readily available to the global academic community, facilitating collaboration and innovation in molecular medicine.

JOURNAL OF MOLECULAR MEDICINE-JMM

Exploring the Intersection of Biochemistry and Clinical Innovation.
Publisher: SPRINGER HEIDELBERGISSN: 0946-2716Frequency: 12 issues/year

JOURNAL OF MOLECULAR MEDICINE (JMM) is a premier publication dedicated to advancing the field of molecular medicine, encompassing critical areas such as drug discovery, genetics, and biochemistry. Published by Springer Heidelberg in Germany, this influential journal has established its significance within the academic community, achieving an impressive Q1 ranking across multiple categories as of 2023, including Drug Discovery, Clinical Genetics, and Molecular Medicine. With a focus on publishing high-quality research and novel insights, JMM appeals to a diverse audience of researchers, professionals, and students passionate about the molecular underpinnings of health and disease. The journal, which has seen a convergence of relevant research spanning from 1976 to 2024, is instrumental in showcasing groundbreaking studies that push the boundaries of knowledge in molecular therapeutics and biomedical science. While it does not offer open access, the rigor of its peer-reviewed content ensures that each publication is a valuable addition to the scientific discourse surrounding molecular medicine. For comprehensive studies and reviews that highlight the intersection of molecular biology and clinical application, look no further than JOURNAL OF MOLECULAR MEDICINE.

STRESS-THE INTERNATIONAL JOURNAL ON THE BIOLOGY OF STRESS

Advancing Knowledge on Stress and Its Impact
Publisher: TAYLOR & FRANCIS LTDISSN: 1025-3890Frequency: 6 issues/year

STRESS - THE INTERNATIONAL JOURNAL ON THE BIOLOGY OF STRESS, published by Taylor & Francis Ltd, is an esteemed open-access journal dedicated to advancing our understanding of stress and its biological underpinnings. Established in 1996 and continuing until 2024, this journal is pivotal in the exploration of stress across multiple dimensions, including its impact on mental health, neurobiology, and endocrine systems. With an impressive categorization in Q2 and Q3 quartiles across various fields such as Behavioral Neuroscience, Psychiatry, and Physiology, STRESS ranks commendably within its discipline, positioning itself as a vital resource for researchers and professionals alike. As of 2022, the journal's open access policy enhances visibility and accessibility, fostering a broader dissemination of knowledge. The journal invites submissions from a diverse range of disciplines, aiming to bridge gaps across fields and encourage interdisciplinary collaboration. By addressing the multifaceted nature of stress, STRESS remains essential for those eager to contribute to this dynamic and critical area of research.

JOURNAL OF TRACE ELEMENTS IN MEDICINE AND BIOLOGY

Connecting Science and Medicine through Trace Element Research
Publisher: ELSEVIER GMBHISSN: 0946-672XFrequency: 6 issues/year

The JOURNAL OF TRACE ELEMENTS IN MEDICINE AND BIOLOGY, published by Elsevier GmbH, stands as a leading platform for disseminating pivotal research in the interdisciplinary field that bridges biochemistry, inorganic chemistry, and molecular medicine. With an impact factor reflective of its high-quality submissions and significant contribution to the scientific community, this journal currently holds a Q2 ranking in Biochemistry and a Q1 ranking in Inorganic Chemistry, underlining its esteemed status among peers. Since its inception in 1995 and continuing through to 2024, the journal has fostered a dynamic discourse on the fundamental roles of trace elements in biological systems, incorporating studies that range from their biochemical functions to their impact on health and disease. Researchers, professionals, and students alike can access a wealth of knowledge, missing Open Access options notwithstanding, making it indispensable for those at the forefront of scientific investigation in medicine and biology.

CELLULAR & MOLECULAR BIOLOGY LETTERS

Pioneering Research in Biochemistry and Cell Biology
Publisher: BMCISSN: 1425-8153Frequency: 1 issue/year

CELLULAR & MOLECULAR BIOLOGY LETTERS, published by BMC, is a premier open-access journal dedicated to disseminating high-quality research in the fields of Biochemistry, Cell Biology, and Molecular Biology. Established in 1996, the journal has emerged as a leader in its domain, boasting an impressive Q1 ranking across three critical categories as of 2023, reflecting its significant impact within the scientific community. With an ISSN of 1425-8153 and an E-ISSN of 1689-1392, it offers accessible research findings to a global audience, having been open access since 2013. Situated in the United Kingdom, at CAMPUS, 4 CRINAN ST, LONDON N1 9XW, the journal continues to serve as a vital resource for researchers, professionals, and students, contributing to advancements in the understanding of cellular and molecular processes. By providing a platform for original research, reviews, and short communications, CELLULAR & MOLECULAR BIOLOGY LETTERS plays a crucial role in fostering dialogue and collaboration within the scientific community.